Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 849447821 | 8494478 | 21 | F | 20120309 | 20160721 | 20120404 | 20160725 | EXP | CA-ROCHE-1052601 | ROCHE | 68.45 | YR | F | Y | 80.00000 | KG | 20160725 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 849447821 | 8494478 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | LATEST INFUSION: 16/MAY/2014 | H06538073,H0161 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||
| 849447821 | 8494478 | 2 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | LATEST INFUSION: 29/MAY/2015 | H06538073,H0161 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||
| 849447821 | 8494478 | 3 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | Y | 17581 | ||||||||||
| 849447821 | 8494478 | 4 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
| 849447821 | 8494478 | 5 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 849447821 | 8494478 | 6 | C | PANTOLOC | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 849447821 | 8494478 | 7 | C | APO-HYDRO | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 849447821 | 8494478 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 849447821 | 8494478 | 9 | C | ZOPICLONE | ZOPICLONE | 1 | 0 | ||||||||||||
| 849447821 | 8494478 | 10 | C | ADALAT | NIFEDIPINE | 1 | 0 | ||||||||||||
| 849447821 | 8494478 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 849447821 | 8494478 | 12 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 849447821 | 8494478 | 13 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 50 | MG | |||||||||
| 849447821 | 8494478 | 14 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 849447821 | 8494478 | 15 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 50 | MG | |||||||||
| 849447821 | 8494478 | 16 | C | ZOSTAVAX | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN | 1 | Unknown | 0 | |||||||||||
| 849447821 | 8494478 | 17 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | |||||||||
| 849447821 | 8494478 | 18 | C | DUROLANE | HYALURONIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 849447821 | 8494478 | 1 | Rheumatoid arthritis |
| 849447821 | 8494478 | 3 | Rheumatoid arthritis |
| 849447821 | 8494478 | 4 | Premedication |
| 849447821 | 8494478 | 13 | Premedication |
| 849447821 | 8494478 | 17 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 849447821 | 8494478 | HO |
| 849447821 | 8494478 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 849447821 | 8494478 | Arthralgia | |
| 849447821 | 8494478 | Asthma | |
| 849447821 | 8494478 | Balance disorder | |
| 849447821 | 8494478 | Blood glucose decreased | |
| 849447821 | 8494478 | Blood potassium decreased | |
| 849447821 | 8494478 | Blood pressure increased | |
| 849447821 | 8494478 | Cataract | |
| 849447821 | 8494478 | Contusion | |
| 849447821 | 8494478 | Dizziness | |
| 849447821 | 8494478 | Drug administration error | |
| 849447821 | 8494478 | Eye disorder | |
| 849447821 | 8494478 | Fall | |
| 849447821 | 8494478 | Fatigue | |
| 849447821 | 8494478 | Foot deformity | |
| 849447821 | 8494478 | Foot fracture | |
| 849447821 | 8494478 | Gait disturbance | |
| 849447821 | 8494478 | Hypotension | |
| 849447821 | 8494478 | Increased tendency to bruise | |
| 849447821 | 8494478 | Infusion related reaction | |
| 849447821 | 8494478 | Laceration | |
| 849447821 | 8494478 | Localised infection | |
| 849447821 | 8494478 | Pain | |
| 849447821 | 8494478 | Pain in extremity | |
| 849447821 | 8494478 | Pneumonia | |
| 849447821 | 8494478 | Rheumatoid arthritis | |
| 849447821 | 8494478 | Skin abrasion | |
| 849447821 | 8494478 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 849447821 | 8494478 | 1 | 20110816 | 0 | ||
| 849447821 | 8494478 | 2 | 20141016 | 0 | ||
| 849447821 | 8494478 | 3 | 201308 | 0 | ||
| 849447821 | 8494478 | 4 | 20110901 | 0 | ||
| 849447821 | 8494478 | 13 | 20110901 | 0 | ||
| 849447821 | 8494478 | 14 | 20130527 | 0 | ||
| 849447821 | 8494478 | 15 | 20110901 | 0 | ||
| 849447821 | 8494478 | 16 | 20131104 | 0 | ||
| 849447821 | 8494478 | 17 | 20130527 | 0 |